Product Code:42372
Published Date: Mar 23,2021
Pages: 86
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this latest study, the 2021 growth of Antibody-drug Conjugates will have significant change from previous year. By the most conservative estimates of global Antibody-drug Conjugates market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2674.9 million in 2020. Over the next five years the Antibody-drug Conjugates market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 3236 million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Antibody-drug Conjugates market by product type, application, key manufacturers and key regions and countries. Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7. Adcetris Kadcyla Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8. Breast Cancer Lymphoma This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3. ImmunoGen Seattle Genetics Roche Takeda
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody-drug Conjugates Consumption 2016-2026
2.1.2 Antibody-drug Conjugates Consumption CAGR by Region
2.2 Antibody-drug Conjugates Segment by Type
2.2.1 Adcetris
2.2.2 Kadcyla
2.3 Antibody-drug Conjugates Sales by Type
2.3.1 Global Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2016-2021)
2.3.3 Global Antibody-drug Conjugates Sale Price by Type (2016-2021)
2.4 Antibody-drug Conjugates Segment by Application
2.4.1 Breast Cancer
2.4.2 Lymphoma
2.5 Antibody-drug Conjugates Sales by Application
2.5.1 Global Antibody-drug Conjugates Sale Market Share by Application (2016-2021)
2.5.2 Global Antibody-drug Conjugates Revenue and Market Share by Application (2016-2021)
2.5.3 Global Antibody-drug Conjugates Sale Price by Application (2016-2021)
3 Global Antibody-drug Conjugates by Company
3.1 Global Antibody-drug Conjugates Sales Market Share by Company
3.1.1 Global Antibody-drug Conjugates Sales by Company (2019-2021)
3.1.2 Global Antibody-drug Conjugates Sales Market Share by Company (2019-2021)
3.2 Global Antibody-drug Conjugates Revenue Market Share by Company
3.2.1 Global Antibody-drug Conjugates Revenue by Company (2019-2021)
3.2.2 Global Antibody-drug Conjugates Revenue Market Share by Company (2019-2021)
3.3 Global Antibody-drug Conjugates Sale Price by Company
3.4 Global Manufacturers Antibody-drug Conjugates Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody-drug Conjugates Product Location Distribution
3.4.2 Players Antibody-drug Conjugates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Antibody-drug Conjugates by Region
4.1 Global Antibody-drug Conjugates by Region
4.1.1 Global Antibody-drug Conjugates Sales by Region
4.1.2 Global Antibody-drug Conjugates Revenue by Region
4.2 Americas Antibody-drug Conjugates Sales Growth
4.3 APAC Antibody-drug Conjugates Sales Growth
4.4 Europe Antibody-drug Conjugates Sales Growth
4.5 Middle East & Africa Antibody-drug Conjugates Sales Growth
5 Americas
5.1 Americas Antibody-drug Conjugates Sales by Country
5.1.1 Americas Antibody-drug Conjugates Sales by Country (2016-2021)
5.1.2 Americas Antibody-drug Conjugates Revenue by Country (2016-2021)
5.2 Americas Antibody-drug Conjugates Sales by Type
5.3 Americas Antibody-drug Conjugates Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody-drug Conjugates Sales by Region
6.1.1 APAC Antibody-drug Conjugates Sales by Region (2016-2021)
6.1.2 APAC Antibody-drug Conjugates Revenue by Region (2016-2021)
6.2 APAC Antibody-drug Conjugates Sales by Type
6.3 APAC Antibody-drug Conjugates Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibody-drug Conjugates by Country
7.1.1 Europe Antibody-drug Conjugates Sales by Country (2016-2021)
7.1.2 Europe Antibody-drug Conjugates Revenue by Country (2016-2021)
7.2 Europe Antibody-drug Conjugates Sales by Type
7.3 Europe Antibody-drug Conjugates Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody-drug Conjugates by Country
8.1.1 Middle East & Africa Antibody-drug Conjugates Sales by Country (2016-2021)
8.1.2 Middle East & Africa Antibody-drug Conjugates Revenue by Country (2016-2021)
8.2 Middle East & Africa Antibody-drug Conjugates Sales by Type
8.3 Middle East & Africa Antibody-drug Conjugates Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antibody-drug Conjugates Distributors
10.3 Antibody-drug Conjugates Customer
11 Global Antibody-drug Conjugates Market Forecast
11.1 Global Antibody-drug Conjugates Forecast by Region
11.1.1 Global Antibody-drug Conjugates Forecast by Regions (2021-2026)
11.2.2 Global Antibody-drug Conjugates Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Antibody-drug Conjugates Forecast by Type
11.7 Global Antibody-drug Conjugates Forecast by Application
12 Key Players Analysis
12.1 ImmunoGen
12.1.1 ImmunoGen Company Information
12.1.2 ImmunoGen Antibody-drug Conjugates Product Offered
12.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 ImmunoGen Main Business Overview
12.1.5 ImmunoGen Latest Developments
12.2 Seattle Genetics
12.2.1 Seattle Genetics Company Information
12.2.2 Seattle Genetics Antibody-drug Conjugates Product Offered
12.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Seattle Genetics Main Business Overview
12.2.5 Seattle Genetics Latest Developments
12.3 Roche
12.3.1 Roche Company Information
12.3.2 Roche Antibody-drug Conjugates Product Offered
12.3.3 Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Roche Main Business Overview
12.3.5 Roche Latest Developments
12.4 Takeda
12.4.1 Takeda Company Information
12.4.2 Takeda Antibody-drug Conjugates Product Offered
12.4.3 Takeda Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Takeda Main Business Overview
12.4.5 Takeda Latest Developments
13 Research Findings and Conclusion
List of Tables Table 1. Antibody-drug Conjugates Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Adcetris Table 3. Major Players of Kadcyla Table 4. Global Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 5. Global Antibody-drug Conjugates Sales Market Share by Type (2016-2021) Table 6. Global Antibody-drug Conjugates Revenue by Type (2016-2021) & ($ million) Table 7. Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2021) Table 8. Global Antibody-drug Conjugates Sale Price by Type (2016-2021) Table 9. Global Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 10. Global Antibody-drug Conjugates Sales Market Share by Application (2016-2021) Table 11. Global Antibody-drug Conjugates Value by Application (2016-2021) Table 12. Global Antibody-drug Conjugates Revenue Market Share by Application (2016-2021) Table 13. Global Antibody-drug Conjugates Sale Price by Application (2016-2021) Table 14. Global Antibody-drug Conjugates Sales by Company (2019-2021) & (Kg) Table 15. Global Antibody-drug Conjugates Sales Market Share by Company (2019-2021) Table 16. Global Antibody-drug Conjugates Revenue by Company (2019-2021) ($ Millions) Table 17. Global Antibody-drug Conjugates Revenue Market Share by Company (2019-2021) Table 18. Global Antibody-drug Conjugates Sale Price by Company (2019-2021) Table 19. Key Manufacturers Antibody-drug Conjugates Producing Area Distribution and Sales Area Table 20. Players Antibody-drug Conjugates Products Offered Table 21. Antibody-drug Conjugates Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Antibody-drug Conjugates Sales by Region (2016-2021) (Kg) Table 25. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021) Table 26. Global Antibody-drug Conjugates Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Antibody-drug Conjugates Revenue Market Share by Region (2016-2021) Table 28. Americas Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg) Table 29. Americas Antibody-drug Conjugates Sales Market Share by Country (2016-2021) Table 30. Americas Antibody-drug Conjugates Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Antibody-drug Conjugates Revenue Market Share by Country (2016-2021) Table 32. Americas Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 33. Americas Antibody-drug Conjugates Sales Market Share by Type (2016-2021) Table 34. Americas Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 35. Americas Antibody-drug Conjugates Sales Market Share by Application (2016-2021) Table 36. APAC Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg) Table 37. APAC Antibody-drug Conjugates Sales Market Share by Region (2016-2021) Table 38. APAC Antibody-drug Conjugates Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Antibody-drug Conjugates Revenue Market Share by Region (2016-2021) Table 40. APAC Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 41. APAC Antibody-drug Conjugates Sales Market Share by Type (2016-2021) Table 42. APAC Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 43. APAC Antibody-drug Conjugates Sales Market Share by Application (2016-2021) Table 44. Europe Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg) Table 45. Europe Antibody-drug Conjugates Sales Market Share by Country (2016-2021) Table 46. Europe Antibody-drug Conjugates Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Antibody-drug Conjugates Revenue Market Share by Country (2016-2021) Table 48. Europe Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 49. Europe Antibody-drug Conjugates Sales Market Share by Type (2016-2021) Table 50. Europe Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 51. Europe Antibody-drug Conjugates Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg) Table 53. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Antibody-drug Conjugates Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Antibody-drug Conjugates Sales by Type (2016-2021) & (Kg) Table 57. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Antibody-drug Conjugates Sales by Application (2016-2021) & (Kg) Table 59. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Antibody-drug Conjugates Table 61. Key Application and Potential Industries of Antibody-drug Conjugates Table 62. Key Challenges of Antibody-drug Conjugates Table 63. Key Trends of Antibody-drug Conjugates Table 64. Antibody-drug Conjugates Distributors List Table 65. Antibody-drug Conjugates Customer List Table 66. Global Antibody-drug Conjugates Sales Forecast by Region (2021-2026) & (Kg) Table 67. Global Antibody-drug Conjugates Consumption Market Forecast by Region Table 68. Global Antibody-drug Conjugates Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Antibody-drug Conjugates Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Antibody-drug Conjugates Sales Forecast by Country (2021-2026) & (Kg) Table 71. Americas Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Antibody-drug Conjugates Sales Forecast by Region (2021-2026) & (Kg) Table 73. APAC Antibody-drug Conjugates Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Antibody-drug Conjugates Sales Forecast by Country (2021-2026) & (Kg) Table 75. Europe Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Antibody-drug Conjugates Sales Forecast by Country (2021-2026) & (Kg) Table 77. Middle East & Africa Antibody-drug Conjugates Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Antibody-drug Conjugates Sales Forecast by Type (2021-2026) & (Kg) Table 79. Global Antibody-drug Conjugates Sales Market Share Forecast by Type (2021-2026) Table 80. Global Antibody-drug Conjugates Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Antibody-drug Conjugates Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Antibody-drug Conjugates Sales Forecast by Application (2021-2026) & (Kg) Table 83. Global Antibody-drug Conjugates Sales Market Share Forecast by Application (2021-2026) Table 84. Global Antibody-drug Conjugates Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Antibody-drug Conjugates Revenue Market Share Forecast by Application (2021-2026) Table 86. ImmunoGen Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors Table 87. ImmunoGen Antibody-drug Conjugates Product Offered Table 88. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 89. ImmunoGen Main Business Table 90. ImmunoGen Latest Developments Table 91. Seattle Genetics Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors Table 92. Seattle Genetics Antibody-drug Conjugates Product Offered Table 93. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 94. Seattle Genetics Main Business Table 95. Seattle Genetics Latest Developments Table 96. Roche Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors Table 97. Roche Antibody-drug Conjugates Product Offered Table 98. Roche Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 99. Roche Main Business Table 100. Roche Latest Developments Table 101. Takeda Basic Information, Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors Table 102. Takeda Antibody-drug Conjugates Product Offered Table 103. Takeda Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 104. Takeda Main Business Table 105. Takeda Latest Developments List of Figures Figure 1. Picture of Antibody-drug Conjugates Figure 2. Antibody-drug Conjugates Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Antibody-drug Conjugates Sales Growth Rate 2016-2026 (Kg) Figure 7. Global Antibody-drug Conjugates Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Antibody-drug Conjugates Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Adcetris Figure 10. Product Picture of Kadcyla Figure 11. Global Antibody-drug Conjugates Sales Market Share by Type in 2020 Figure 12. Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2021) Figure 13. Antibody-drug Conjugates Consumed in Breast Cancer Figure 14. Global Antibody-drug Conjugates Market: Breast Cancer (2016-2021) & (Kg) Figure 15. Antibody-drug Conjugates Consumed in Lymphoma Figure 16. Global Antibody-drug Conjugates Market: Lymphoma (2016-2021) & (Kg) Figure 17. Global Antibody-drug Conjugates Sales Market Share by Application (2016-2021) Figure 18. Global Antibody-drug Conjugates Revenue Market Share by Application in 2020 Figure 19. Antibody-drug Conjugates Revenue Market by Company in 2020 ($ Million) Figure 20. Global Antibody-drug Conjugates Revenue Market Share by Company in 2020 Figure 21. Global Antibody-drug Conjugates Sales Market Share by Regions (2016-2021) Figure 22. Global Antibody-drug Conjugates Revenue Market Share by Region in 2020 Figure 23. Americas Antibody-drug Conjugates Sales 2016-2021 (Kg) Figure 24. Americas Antibody-drug Conjugates Revenue 2016-2021 ($ Millions) Figure 25. APAC Antibody-drug Conjugates Sales 2016-2021 (Kg) Figure 26. APAC Antibody-drug Conjugates Revenue 2016-2021 ($ Millions) Figure 27. Europe Antibody-drug Conjugates Sales 2016-2021 (Kg) Figure 28. Europe Antibody-drug Conjugates Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Antibody-drug Conjugates Sales 2016-2021 (Kg) Figure 30. Middle East & Africa Antibody-drug Conjugates Revenue 2016-2021 ($ Millions) Figure 31. Americas Antibody-drug Conjugates Sales Market Share by Country in 2020 Figure 32. Americas Antibody-drug Conjugates Revenue Market Share by Country in 2020 Figure 33. Americas Antibody-drug Conjugates Sales Market Share by Type in 2020 Figure 34. Americas Antibody-drug Conjugates Sales Market Share by Application in 2020 Figure 35. United States Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Antibody-drug Conjugates Sales Market Share by Region in 2020 Figure 40. APAC Antibody-drug Conjugates Revenue Market Share by Regions in 2020 Figure 41. APAC Antibody-drug Conjugates Sales Market Share by Type in 2020 Figure 42. APAC Antibody-drug Conjugates Sales Market Share by Application in 2020 Figure 43. China Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 47. India Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Antibody-drug Conjugates Sales Market Share by Country in 2020 Figure 50. Europe Antibody-drug Conjugates Revenue Market Share by Country in 2020 Figure 51. Europe Antibody-drug Conjugates Sales Market Share by Type in 2020 Figure 52. Europe Antibody-drug Conjugates Sales Market Share by Application in 2020 Figure 53. Germany Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 54. France Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Application in 2020 Figure 62. Egypt Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Antibody-drug Conjugates Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles
ImmunoGen Seattle Genetics Roche Takeda
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Aug
2020
Global Antibody-drug Conjugates Market Growth 2020-2025
Pages: 134|Category: PHARMA & HEALTHCARE
According to this study, over the next five years the Antibody-drug Conjugates market will register a 3.1%% CAGR in terms of revenue, the global market size will reach $ 2926.2 million by 2025, from $ 2588.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antibody-drug Conjugates business, shared in Chapter 3.
$3660.00